4.6 Article

Role of Macrophage Migration Inhibitory Factor in the Th2 Immune Response to Epicutaneous Sensitization

Journal

JOURNAL OF CLINICAL IMMUNOLOGY
Volume 31, Issue 4, Pages 666-680

Publisher

SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s10875-011-9541-7

Keywords

Atopic inflammation; macrophage migration inhibitory factor; Th2 response

Categories

Funding

  1. NIH [2 T32 AR 007107-36, AR050498, AR049610, AI069396, T30-AR07016]
  2. Yale-New Haven Hospital
  3. Dermatology Foundation

Ask authors/readers for more resources

We examined the role of macrophage migration inhibitory factor (MIF) in the generation of the Th2 response using MIF-deficient mice in a model of epicutaneous sensitization to ovalbumin. Lymph node cells from sensitized MIF-deficient mice produce lower levels of Th2 cytokines after antigen challenge when compared to their wild-type counterparts. Sensitized mice lacking MIF show less pulmonary inflammation after intranasal antigen exposure. Mice deficient in CD74, the MIF receptor, also are unable to generate an inflammatory response to epicutaneous sensitization. Examination of the elicitation phase of the atopic response using DO11.10 OVA TCR transgenic animals shows that T cell proliferation and IL-2 production are strongly impaired in MIF-deficient T cells. This defect is most profound when both T cells and antigen-presenting cells are lacking MIF. These data suggest that MIF is crucial both for the sensitization and the elicitation phases of a Th2-type immune response in allergic disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available